Abnormal SOC channels activities cause several human diseases, such as breast cancer [6,7,8], inflammatory bowel diseases [9], thrombosis [10], and severe combined immunodeficiency (SCID) disorders [11], which leads to an increasing interest in developing small molecule compounds to regulate aberrant SOC and especially CRAC channels function [12]. This evidence concerns the gene UBXN11 and inflammatory bowel disease.